SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Heit JA, Melton LJ, III, Lohse CM, et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 2001; 76(11): 11021110.
  • 2
    Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. world health organization collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1995; 346(8990): 15751582.
  • 3
    Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 8289.
  • 4
    Smith NL, Heckbert SR, Lemaitre RN, et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004; 292(13): 15811587.
  • 5
    Spencer FA, Emery C, Joffe SW, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. the worcester VTE study. J Thromb Thrombolysis 2009; 28(4): 401409.
  • 6
    Gerstman BB, Freiman JP, Hine LK. Use of subsequent anticoagulants to increase the predictive value of medicaid deep venous thromboembolism diagnoses. Epidemiology 1990; 1(2): 122127.
  • 7
    Willey VJ, Bullano MF, Hauch O, et al. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting. Clin Ther 2004; 26(7): 11491159.
  • 8
    Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and PE in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117(1): 1925.
  • 9
    Henderson KE, Recktenwald A, Reichley RM, et al. Clinical validation of the AHRQ postoperative venous thromboembolism patient safety indicator. Jt Comm J Qual Patient Saf 2009; 35(7): 370376.
  • 10
    Leibson CL, Needleman J, Buerhaus P, et al. Identifying in-hospital venous thromboembolism (VTE): A comparison of claims-based approaches with the rochester epidemiology project VTE cohort. Med Care 2008; 46(2): 127132.
  • 11
    Kniffin WD, Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA, Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154(8): 861866.
  • 12
    Spencer FA, Emery C, Lessard D, et al. The worcester venous thromboembolism study: A population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21(7): 722727.
  • 13
    Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167(14): 14711475.
  • 14
    Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G. Management of acute proximal deep vein thrombosis: Pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest 2002; 122(1): 108114.
  • 15
    White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 2000; 343(24): 17581764.
  • 16
    White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158(14): 15251531.
  • 17
    McCarthy EP, Iezzoni LI, Davis RB, et al. Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care 2000; 38(8): 868876.
  • 18
    White RH, Brickner LA, Scannell KA. ICD-9-CM codes poorly indentified venous thromboembolism during pregnancy. J Clin Epidemiol 2004; 57(9): 985988.
  • 19
    Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133(6 Suppl): 381S453S.
  • 20
    Blann AD, Lip GY. Venous thromboembolism. BMJ 2006; 332(7535): 215219.
  • 21
    Anderson FA, Jr, Wheeler HB. Physician practices in the management of venous thromboembolism: A community-wide survey. J Vasc Surg 1992; 16(5): 707714.
  • 22
    Hedenmalm K, Samuelsson E. Fatal venous thromboembolism associated with different combined oral contraceptives: A study of incidences and potential biases in spontaneous reporting. Drug Saf 2005; 28(10): 907916.
  • 23
    Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. heart and Estrogen/progestin replacement study (HERS) research group. JAMA 1998; 280(7): 605613.
  • 24
    Lundgren R, Sundin T, Colleen S, et al. Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study. Scand J Urol Nephrol 1986; 20(2): 101105.
  • 25
    Hogberg U. Maternal deaths in sweden, 1971–1980. Acta Obstet Gynecol Scand 1986; 65(2): 161167.
  • 26
    Zhan C, Battles J, Chiang YP, Hunt D. The validity of ICD-9-CM codes in identifying postoperative deep vein thrombosis and pulmonary embolism. Jt Comm J Qual Patient Saf 2007; 33(6): 326331.
  • 27
    Anderson FA, Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. the worcester DVT study. Arch Intern Med 1991; 151(5): 933938.
  • 28
    Weingart SN, Iezzoni LI, Davis RB, et al. Use of administrative data to find substandard care: Validation of the complications screening program. Med Care 2000; 38(8): 796806.
  • 29
    Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data. is it valid? Med Care 2000; 38(8): 785795.